11 research outputs found
Hepatitis reactivation in patients with rheumatic diseases after immunosuppressive therapy—a report of long-term follow-up of serial cases and literature review
WATERMELON STOMACH IN SYSTEMIC SCLEROSIS: A EUSTAR CASE-CONTROL STUDY
Absence of antitopoisomerase I antibodies and presence of antibodies to RNA-Polymerase-III
antibodies may be useful to identify the subset of SSc patients with increased risk for GAVE. Despite it was
described as a late complication, SSc patients with GAVE had early disease duration. GAVE appears as a cause of
anaemia that clinicians should be aware of. This complication often requires local endoscopic therapy, which is
usually efficient, despite frequent recurrent events. The inclusion of further cases in this ongoing project may help to
better characterise the features of this rare complication